Magenta Therapeutics (MGTA) EBITDA (2018 - 2023)
Magenta Therapeutics (MGTA) EBITDA from Jun 30, 2018 to Jun 30, 2023. The TTM Magenta Therapeutics (MGTA) EBITDA is -$39M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Magenta Therapeutics (MGTA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -49.73% |
| 3 Years TTM | -23.13% |
| 5 Years TTM | +23.19% |
| All Time TTM | -13.07% |
Annual EBITDA change of Magenta Therapeutics (MGTA)
| Year | EBITDA | Change |
|---|---|---|
| 2023 | -$19M | -34.51% |
| 2022 | -$30M | -59.17% |
| 2021 | -$73M | -5.28% |
| 2020 | -$77M | -5.44% |
| 2019 | -$81M | +37.30% |
| 2018 | -$59M | N/A |